Paper37814183
Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma.
Wakizaka K and 7 others. Ann Surg Oncol, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma. Papers, record 37814183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37814183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt-Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Cell Differentiation | |
| Prognosis | |
| Receptor Tyrosine Kinase-like Orphan Receptors | |
| Wnt Signaling Pathway | |
| Wnt-5a Protein |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP23K15466 | Japan Society for the Promotion of Science | PubMed | ||
| GSK Japan Research Grant 2017 | GSK Japan Research Grant | PubMed | ||
| JP19fk0210018 | Japan Agency for Medical Research and Development | PubMed |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19259739 | Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization. | Ann Surg Oncol | 2009 | https://conductscience.org/library/papers/19259739 | PubMed |
| 2 | 17188462 | Multiplicity of the interactions of Wnt proteins and their receptors. | Cell Signal | 2007 | https://conductscience.org/library/papers/17188462 | PubMed |
| 3 | 28575679 | Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. | Cell | 2017 | https://conductscience.org/library/papers/28575679 | PubMed |
| 4 | 15473860 | The Wnt signaling pathway in development and disease. | Annu Rev Cell Dev Biol | 2004 | https://conductscience.org/library/papers/15473860 | PubMed |
| 5 | 27571105 | Wnt5a Signaling in Cancer. | Cancers (Basel) | 2016 | https://conductscience.org/library/papers/27571105 | PubMed |
| 6 | 19736321 | Towards an integrated view of Wnt signaling in development. | Development | 2009 | https://conductscience.org/library/papers/19736321 | PubMed |
| 7 | 32989402 | Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32989402 | PubMed |
| 8 | 22493546 | Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22493546 | PubMed |
| 9 | 12839624 | The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. | Genes Cells | 2003 | https://conductscience.org/library/papers/12839624 | PubMed |
| 10 | 21342370 | Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. | Genes Cells | 2011 | https://conductscience.org/library/papers/21342370 | PubMed |
| 11 | 11429290 | Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. | Mech Dev | 2001 | https://conductscience.org/library/papers/11429290 | PubMed |
| 12 | 30826310 | Purification and characterization of the extracellular region of human receptor tyrosine kinase like orphan receptor 2 (ROR2). | Protein Expr Purif | 2019 | https://conductscience.org/library/papers/30826310 | PubMed |
| 13 | 19448672 | Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. | Oncogene | 2009 | https://conductscience.org/library/papers/19448672 | PubMed |
| 14 | 19217015 | Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity. | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | 2009 | https://conductscience.org/library/papers/19217015 | PubMed |
| 15 | 19802008 | The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. | Oncogene | 2010 | https://conductscience.org/library/papers/19802008 | PubMed |
| 16 | 23208313 | Investigation of the freely available easy-to-use software 'EZR' for medical statistics. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23208313 | PubMed |
| 17 | 15757804 | Histopathology of liver cancers. | Best Pract Res Clin Gastroenterol | 2005 | https://conductscience.org/library/papers/15757804 | PubMed |
| 18 | 32509204 | Dedifferentiation of hepatocellular carcinoma: molecular mechanisms and therapeutic implications. | Am J Transl Res | 2020 | https://conductscience.org/library/papers/32509204 | PubMed |
| 19 | 19849855 | Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. | Mol Cancer | 2009 | https://conductscience.org/library/papers/19849855 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42586960 | Translational insights and clinical challenges of targeting cancer stem cells. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42586960 | PubMed |
| 42138208 | Spatial hepatology: Decoding liver zonation for metabolic and regenerative therapeutics (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42138208 | PubMed |
| 41301815 | Drug-Metabolizing Gene Expression Identity: Comparison Across Liver Tissues and Model Cell Lines. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301815 | PubMed |
| 41120801 | WNT signaling in cancer: molecular mechanisms and potential therapies. | Mol Biomed | 2025 | https://conductscience.org/library/papers/41120801 | PubMed |
| 41029313 | MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41029313 | PubMed |
| 40606304 | Wnt/Ca2+ signaling: Dichotomous roles in regulating tumor progress (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/40606304 | PubMed |
| 40180907 | Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40180907 | PubMed |
| 39682738 | Wnt Signaling in Hepatocellular Carcinoma: Biological Mechanisms and Therapeutic Opportunities. | Cells | 2024 | https://conductscience.org/library/papers/39682738 | PubMed |
| 39347881 | Novel biomarkers and drug correlations of non-canonical WNT signaling in prostate and breast cancer. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39347881 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37814183
GET https://conductscience.org/api/papers/v1/37814183/authors